论文部分内容阅读
随着中国加入“世贸组织”时间的临近,民族医药产业压力日大,零敲碎打,难御“强敌”。走规模经济、集约化经营之路,形成市场领导企业,建立统一市场,已成当务之急。 《经济参考报》日前报道了深圳国有医药企业从“一
With the advent of China’s accession to the “WTO”, the pressure on the national pharmaceutical industry will increase day by day and it will be difficult to defend against “strong enemies”. Taking the road of economies of scale and intensive management, forming market leading enterprises and establishing a unified market have become an urgent matter. The “Economic Information Daily” reported on the Shenzhen State-owned pharmaceutical companies